Table 1.
Neurological and neuropsychological scores in 11 patients with Parkinson's disease before and after bilateral STN-DBS
| Variables | Preop. | Postop. | P value |
|---|---|---|---|
| Motor function | |||
| UPDRS part III on | 18.5 ± 9.10 | 13.5 ± 5.0 | 0.1563 |
| UPDRS part III off | 34.9 ± 13.3 | 21.1 ± 9.7 | < 0.01 * |
| LED (mg) | 487.6 ± 150.5 | 296.7 ± 176.3 | < 0.01 * |
| Neuropsychological tests | |||
| MMSE | 26.1 ± 4.2 | 25.5 ± 2.4 | 0.2324 |
| JART | 93.8 ± 9.3 | 94.5 ± 8.6 | 0.6680 |
| WAIS-R total score | 83.1 ± 11.0 | 83.4 ± 9.1 | 0.7266 |
| RBANS total score | 76.2 ± 8.9 | 76.6 ± 12.4 | 0.7266 |
*Statistically significant. JART: Japanese adult reading test, LED: levodopa equivalent doses, MMSE: mini-mental scale examination, RBANS: repeatable battery for the assessment of neuropsychological status, STN-DBS: subthalamic nucleus deep brain stimulation, UPDRS: unified Parkinson's disease rating scale, WAIS-R: Wechsler adult intelligence scale-revised.